精子捐赠者限制的发生率与指征——继续治疗患者的分析:一项回顾性单中心研究
该单中心回顾性研究分析了2010年1月至2019年12月期间进口精子使用受限的捐赠者及接受者,发现1124名捐赠者中200名(17.8%)被限制,最常见原因为多因素(27.5%)和常染色体隐性(17.5%)疾病。172名接受者构成决策队列,约40%接受受限精子,其中约63%最终用于后续治疗;接受受限精子的几率随年龄增长(OR 0.857)和MAR治疗与限制日期间隔延长(OR 0.806)而降低。
要点
- 1124名捐赠者中200名(17.8%)因疑似/确诊疾病风险被限制,常见指征为多因素(27.5%)和常染色体隐性(17.5%)疾病。
- 决策队列172人,约40%接受受限精子,其中约63%最终用于后续MAR治疗。
- 接受受限精子的几率随年龄增长(OR 0.857,95%CI 0.800-0.918)和限制前时间间隔延长(OR 0.806,95%CI 0.713-0.911)而降低。
核心结论
- 因疑似/确诊疾病风险而限制捐赠者相对常见,影响约800名女性,其中172名(约20%)需决定是否继续使用这些捐赠者。
- 尽管捐赠者筛查已全面进行,捐赠子代仍存在健康风险,需要对所有相关方进行符合实际的咨询。
研究设计与样本
- 单中心回顾性研究,纳入2010年1月至2019年12月期间进口精子使用受限的捐赠者及当前或既往接受者。
- 收集限制指征及限制时接受MAR治疗患者的特征,评估决定继续或停止治疗的女性的差异特征。
主要发现
- 1124名捐赠者中200名(17.8%)被限制,最常见为多因素(27.5%)和常染色体隐性(17.5%)疾病。
- 受限精子曾用于798名接受者,其中172名(接受来自100名捐赠者的精子)被告知限制,构成决策队列。
- 71名(约40%)患者接受受限捐赠者的标本,其中45名(约63%)最终用于未来MAR治疗。
- 接受受限精子的几率随年龄增长而降低(OR 0.857,95%CI 0.800-0.918,P<0.001)。
- 接受受限精子的几率随MAR治疗与限制日期之间的时间间隔延长而降低(OR 0.806,95%CI 0.713-0.911,P<0.001)。
临床怎么用
- 作者认为需要对所有相关方进行符合实际的咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What are the incidence of and indications for sperm donor restriction due to suspected/confirmed disease risk, and the future treatment choices of patients using these sperm donors? DESIGN: This single-centre retrospective study involved donors who had restrictions on the use of their imported spermatozoa from January 2010 to December 2019, and current or previous recipients. Indications for sperm restriction and the characteristics of patients undergoing medically assisted reproduction (MAR) treatment with these specimens at the time of restriction were collected. Differential characteristics of women who decided on whether or not to contintue the procedure were assessed. Characteristics potentially leading to treatment continuation were identified. RESULTS: Of 1124 sperm donors identified, 200 (17.8%) were restricted, most commonly for multifactorial (27.5%) and autosomal recessive (17.5%) disorders. The spermatozoa had been used for 798 recipients, of whom 172, receiving spermatozoa from 100 donors, were informed about the restriction and constituted the 'decision cohort'. The specimens from the restricted donors were accepted by 71 (approximately 40%) patients, with 45 (approximately 63%) eventually using the restricted donor for their future MAR treatment. The odds of accepting the restricted spermatozoa decreased with increasing age (OR 0.857, 95% CI 0.800-0.918, P < 0.001) and the time between MAR treatment and the restriction date (OR 0.806, 95% CI 0.713-0.911, P < 0.001). CONCLUSION: Donor restriction due to suspected/confirmed disease risk is relatively frequent. This affected a relevant number of women (around 800), of whom 172 (approximately 20%) had to decide whether or not to use these donors further. Although donor screening is being performed thoroughly, there remain health risks for donor children. Realistic counselling of all stakeholders involved is necessary.
引用
- Vanbelleghem E, Muyshond V, Colman R, et al. Incidence of and indications for sperm donor restriction - analysis of patients continuing treatment: a retrospective single-centre study. Reprod Biomed Online. 2023. PMID: 37244865. doi:10.1016/j.rbmo.2023.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。